OTCQB: LXXGF | TSX.V: LXG

BioSpace article on LexaGene antibiotic resistance testing

by | Aug 7, 2019 | Biothreat Detection

Home » Biothreat Detection » BioSpace article on LexaGene antibiotic resistance testing

The CDC and FDA AR Isolate Bank will provide information to LexaGene which will support the company’s diagnostics development and help address the serious issue of antibiotic resistance.

Read More at BioSpace

<a href="https://lexagene.com/author/lexagene-admin/" target="_self">LexaGene</a>

LexaGene

LexaGene is a molecular diagnostics company that has commercialized the MiQLab System for fast and easy detection of biological contaminants, pathogens and other molecular markers.

The Value of a Filter-Based Sample Preparation Cartridge Used in a PCR Device for Sensitive and Rapid Detection of Contaminants

LexaGene’s MiQLab™ System is the only fully automated system on the market today that is equipped with a disposable filter-based sample preparation cartridge that allows for efficient processing of large volumes of sample for sensitive detection of contaminants.

Read More

Survey Says Veterinarians Have an Appetite for In-Clinic Diagnostic Technology

This spring LexaGene conducted a market research survey in conjunction with AAHA to assess the opinions of practicing veterinarians on AMR stewardship and the use of antibiotics in the treatment of companion animals.

Read More

The Dawn of the Superbugs

The most menacing of all resistant bacteria are the so called “super bugs”- strains of bacteria that are resistant to several different classes of antibiotics or multidrug resistant.

Read More
Subscribe for Updates

Upcoming Events

No events in this category to show at this time.

See All Events

Latest Resources

BioThreat Sell Sheet

MiQLab for Rapid Response to Novel Biothreats


LexaGene’s MiQLab™ System, a TRL-7 technology, drastically shortens the time gap between novel pathogen identification and point-of-need testing through its open-access feature.

See All Resources